Zacks Investment Research downgraded shares of HEALTHSTREAM (HSTM) from OUTPERFORM to NEUTRAL on November 20, 2014, with a target price of $34.30.
Healthstream Inc. is pioneering a Web-based solution to meet the training and education needs of the healthcare industry utilizing our proprietary system. Through strategic relationships with medical institutions and commercial organizations, the company has amassed hours of training and education courses. The company distributes hours of these courses online to allied healthcare professionals, nurses, doctors and other healthcare workers.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on HEALTHSTREAM (HSTM),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment